Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · IEX Real-Time Price · USD
1.140
-0.040 (-3.39%)
May 16, 2024, 4:00 PM EDT - Market closed
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $237.89 million as of May 16, 2024. Its market cap has increased by 20.70% in one year.
Market Cap
237.89M
Enterprise Value
243.14M
1-Year Change
20.70%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $237.89M, a decrease of -51.26%. That is a compound annual growth rate of -6.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2024 | 257.80M | -4.66% |
| May 13, 2024 | 270.40M | 6.62% |
| May 10, 2024 | 253.60M | -9.04% |
| May 9, 2024 | 278.80M | -4.88% |
| May 8, 2024 | 293.10M | - |
| May 7, 2024 | 293.10M | -6.06% |
| May 6, 2024 | 312.00M | 8.79% |
| May 3, 2024 | 286.80M | 5.36% |
| May 2, 2024 | 272.20M | 4.85% |
| May 1, 2024 | 259.60M | -1.59% |
| Apr 30, 2024 | 263.80M | -4.56% |
| Apr 29, 2024 | 276.40M | -1.50% |
| Apr 26, 2024 | 280.60M | 0.75% |
| Apr 25, 2024 | 278.50M | -2.89% |
| Apr 24, 2024 | 286.80M | - |
| Apr 23, 2024 | 286.80M | 0.74% |
| Apr 22, 2024 | 284.70M | - |
| Apr 19, 2024 | 284.70M | -2.16% |
| Apr 18, 2024 | 291.00M | - |
| Apr 17, 2024 | 291.00M | -0.72% |
| Apr 16, 2024 | 293.10M | 0.72% |
| Apr 15, 2024 | 291.00M | -4.81% |
| Apr 12, 2024 | 305.70M | -4.56% |
| Apr 11, 2024 | 320.30M | -1.93% |
| Apr 10, 2024 | 326.60M | 1.30% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus BioSciences | 250.10M |
| Pyxis Oncology | 248.46M |
| Metagenomi | 247.77M |
| 908 Devices | 247.43M |
| G1 Therapeutics | 247.03M |
| uniQure | 245.61M |
| Utah Medical Products | 244.87M |
| Omeros | 243.66M |